SHANGHAI, Aug. 12, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the Investigational New Drug (IND) application for AK0406 injection, the company's first long-acting antiviral drug‑Fc conjugate (AFC) candidate for influenza prophylaxis, has...
Hence then, the article about arkbio announces china ind approval for its antiviral drug fc conjugate afc candidate ak0406 for influenza prophylaxis was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ArkBio Announces China IND Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis )
Also on site :
- India Face Brazil Today: Kickoff Time and Broadcast Details
- In 1983, Atari buried about 700,000 game cartridges in an Alamogordo, New Mexico landfill; the 881 that were dug up and sold on eBay brought in more than $107,000
- Elton John started his AIDS foundation in 1992; it has since raised more than $565 million for HIV programs in 90 countries